184 related articles for article (PubMed ID: 18191272)
1. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
2. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
4. Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.
Ala A; Dieterich DT
AIDS Read; 2004 Mar; 14(3):134-5. PubMed ID: 15068001
[No Abstract] [Full Text] [Related]
5. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
[No Abstract] [Full Text] [Related]
6. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
[No Abstract] [Full Text] [Related]
7. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
[No Abstract] [Full Text] [Related]
8. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.
Daudé M; Rostaing L; Sauné K; Lavayssière L; Basse G; Esposito L; Guitard J; Izopet J; Alric L; Kamar N
Transplantation; 2011 Apr; 91(8):916-20. PubMed ID: 21325995
[TBL] [Abstract][Full Text] [Related]
9. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Matthews GV; Dore GJ
AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
[No Abstract] [Full Text] [Related]
10. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
11. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
12. Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand.
Avihingsanon A; Lewin SR; Kerr S; Chang JJ; Piyawat K; Napissanant N; Matthews GV; Dore GJ; Bowden S; Lange J; Ruxrungtham K
Antivir Ther; 2010; 15(6):917-22. PubMed ID: 20834105
[TBL] [Abstract][Full Text] [Related]
13. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Hadziyannis SJ
Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
[No Abstract] [Full Text] [Related]
14. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Jenh AM; Pham PA
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
[TBL] [Abstract][Full Text] [Related]
15. Europe extends Viread indication for chronic hepatitis B.
AIDS Patient Care STDS; 2008 Apr; 22(4):350. PubMed ID: 18434949
[No Abstract] [Full Text] [Related]
16. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
17. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus viral load and treatment decision.
Tillmann H; Patel K; McHutchison J
Hepatology; 2009 Feb; 49(2):699; author reply 701-2. PubMed ID: 19177581
[No Abstract] [Full Text] [Related]
19. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
Liu Y; Wang CM; Cheng J; Liang ZL; Zhong YW; Ren XQ; Xu ZH; Zoulim F; Xu DP
Chin Med J (Engl); 2009 Jul; 122(13):1585-6. PubMed ID: 19719953
[No Abstract] [Full Text] [Related]
20. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
